β€’
Apr 02, 2022

Waters Q1 2022 Earnings Report

Waters' first quarter was marked by record sales, driven by strong instrument growth and recurring revenues.

Key Takeaways

Waters Corporation reported a strong first quarter in 2022, with sales reaching $691 million, a 13% increase as reported and 16% in constant currency. Instrument sales grew by 26% in constant currency, and non-GAAP EPS increased by 22% to $2.80. The company is raising its full-year 2022 guidance for constant currency sales growth and non-GAAP EPS.

Sales of $691 million grew 13% as reported and 16% in constant currency.

Instrument sales grew 26% in constant currency, with strong growth across LC, MS and TA product lines

All end-markets grew, with pharmaceutical and industrial both up high-teens

Broad-based sales growth across all geographies, led by U.S. which grew 28% and China grew 17% in constant currency

Total Revenue
$691M
Previous year: $609M
+13.5%
EPS
$2.8
Previous year: $2.29
+22.3%
Pharma Market Sales
$15
Previous year: $360M
-100.0%
Industrial Market Sales
$14
Previous year: $183M
-100.0%
Gross Profit
$405M
Previous year: $354M
+14.2%
Cash and Equivalents
$480M
Previous year: $684M
-29.8%
Total Assets
$3.04B
Previous year: $3.21B
-5.3%

Waters

Waters

Waters Revenue by Geographic Location

Forward Guidance

The Company expects second quarter 2022 constant currency sales growth in the range of 6% to 8%. Currency translation is expected to decrease second quarter sales growth by approximately four percentage points. The Company expects second quarter 2022 non-GAAP EPS in the range of $2.55 to $2.65.

Revenue & Expenses

Visualization of income flow from segment revenue to net income